Cargando…

N(6)-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA

Double-stranded RNA (dsRNA) is a virus-encoded signature capable of triggering intracellular Rig-like receptors (RLR) to activate antiviral signaling, but whether intercellular dsRNA structural reshaping mediated by the N(6)-methyladenosine (m(6)A) modification modulates this process remains largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Weinan, Zhang, Qingyang, Zhang, Rui, Lu, Yangxu, Wang, Xin, Tian, Huabin, Yang, Ying, Gu, Zijuan, Gao, Yanan, Yang, Xin, Cui, Guanshen, Sun, Baofa, Peng, Yanan, Deng, Hongyu, Peng, Hua, Yang, Angang, Yang, Yun-Gui, Yang, Pengyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952553/
https://www.ncbi.nlm.nih.gov/pubmed/33707441
http://dx.doi.org/10.1038/s41467-021-21904-y
Descripción
Sumario:Double-stranded RNA (dsRNA) is a virus-encoded signature capable of triggering intracellular Rig-like receptors (RLR) to activate antiviral signaling, but whether intercellular dsRNA structural reshaping mediated by the N(6)-methyladenosine (m(6)A) modification modulates this process remains largely unknown. Here, we show that, in response to infection by the RNA virus Vesicular Stomatitis Virus (VSV), the m(6)A methyltransferase METTL3 translocates into the cytoplasm to increase m(6)A modification on virus-derived transcripts and decrease viral dsRNA formation, thereby reducing virus-sensing efficacy by RLRs such as RIG-I and MDA5 and dampening antiviral immune signaling. Meanwhile, the genetic ablation of METTL3 in monocyte or hepatocyte causes enhanced type I IFN expression and accelerates VSV clearance. Our findings thus implicate METTL3-mediated m(6)A RNA modification on viral RNAs as a negative regulator for innate sensing pathways of dsRNA, and also hint METTL3 as a potential therapeutic target for the modulation of anti-viral immunity.